首页 > 市场调查报告书 > 医疗设备

医学影像诊断药物递输设备电子医疗设备内视镜检查设备

市场调查报告书

商品编码

1909128

智慧药丸给药系统市场规模、份额和成长分析（按类型、组件、应用、最终用户、疾病适应症和地区划分）—产业预测（2026-2033 年）

Smart Pills Drug Delivery Market Size, Share, and Growth Analysis, By Type, By Component, By Application, By End User, By Disease Indication, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月29日 | 出版商:

SkyQuest | 英文 197 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球智慧药丸药物传输市场规模预计在 2024 年达到 23.2 亿美元，从 2025 年的 25.6 亿美元成长到 2033 年的 57 亿美元，在预测期（2026-2033 年）内复合年增长率为 10.5%。

全球智慧药丸给药市场受到消化器官系统疾病和慢性疾病（例如大肠直肠癌和糖尿病）日益普遍的显着影响，这些疾病需要持续监测和精准治疗。患者越来越倾向于选择侵入性较小的诊断方法，这使得智慧药丸成为传统方法的有效替代方案。内视镜技术的进步（例如高清成像和无线资料传输）进一步提高了这些口服设备的效率和功能。此外，远端患者监护的趋势也与改善依从性追踪和临床疗效的创新解决方案的需求相契合。然而，该市场也面临着许多挑战，例如高成本、监管障碍和资料安全问题，这些都可能阻碍智慧药丸在医疗保健领域的成长和广泛应用。

全球智慧药丸药物传输市场驱动因素

胃肠道疾病（包括克隆氏症、结肠癌和糖尿病等慢性疾病）发生率的不断上升，显着推动了智慧药丸给药市场的扩张。由于这些疾病需要持续监测和精准诊断，因此智慧药丸对于早期发现和标靶给药至关重要。此外，它们在改善这些疾病的长期管理策略方面也发挥关键作用，最终提供更有效的治疗方案。随着人们对疾病治疗创新解决方案的需求日益增长，智慧药丸正逐渐成为现代医学领域不可或缺的工具，有助于改善患者预后并提高整体医疗效率。

全球智慧药丸药物输送市场面临的限制因素

全球智慧药丸给药市场面临许多挑战，其中最主要的原因是这些先进技术高成本，限制了许多病患和医疗机构的取得。智慧药丸的生产和部署成本高昂，对医院而言构成了一大障碍，尤其是在预算紧张的情况下。此外，缺乏广泛的保险覆盖加剧了这个问题，成为智慧药丸技术普及应用的一大阻碍。因此，这些经济限制阻碍了智慧药丸在医疗保健领域的大规模应用，也限制了智慧药丸为许多需要创新治疗方案的患者带来的益处。

全球智慧药丸药物传输市场趋势

全球智慧药丸市场正经历一场变革，人工智慧 (AI) 的融入彻底改变了患者照护。这些创新胶囊能够分析即时数据并提供预测性见解，透过在异常情况恶化之前识别出来，从而增强慢性病管理。人工智慧也能透过推荐最佳用药时间来支援个人化治疗方案，提升病患的用药依从性和治疗效果。这些智慧药丸可与电子健康记录无缝集成，协助精准医疗转型，实现个人化的医疗保健体验。这种模式转移使人工智慧增强型智慧药丸成为未来医药发展领域的前沿力量。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic plc
Olympus Corp
Philips NV
CapsoVision Inc.
Jinshan Science & Tech
Check-Cap Ltd.
etectRx Inc.
Otsuka Pharmaceutical Co.
HQ Inc.
IntroMedic Co.
BodyCap Medical
Proteus Digital Health
RF Tracking Systems
AnX Robotica
Chongqing Science & Tech
Karl Storz SE & Co. KG
Fujifilm Holdings Corp
Boston Scientific Corp

结论与建议

简介目录

Product Code: SQMIG35A3073

Global Smart Pills Drug Delivery Market size was valued at USD 2.32 Billion in 2024 and is poised to grow from USD 2.56 Billion in 2025 to USD 5.7 Billion by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).

The Global Smart Pills Drug Delivery Market is significantly influenced by the increasing prevalence of gastrointestinal and chronic diseases, such as colorectal cancer and diabetes, which require continuous monitoring and precise treatment. Patients are increasingly favoring less invasive diagnostic methods, positioning smart pills as a viable alternative to traditional approaches. Technological advancements in endoscopy, including enhanced imaging and wireless data transmission, have further improved the efficiency and functionality of these ingestible devices. Additionally, the shift towards remote patient monitoring aligns with the need for innovative solutions that enhance compliance tracking and clinical outcomes. However, the market faces challenges such as high device costs, regulatory hurdles, and concerns surrounding data security, which can hinder the growth and adoption of smart pills in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Drug Delivery Market Segments Analysis

Global Smart Pills Drug Delivery Market is segmented by Type, Component, Application, End User, Disease Indication and region. Based on Type, the market is segmented into Capsule Endoscopy, Patient Monitoring Smart Pills and Drug-Delivery Smart Pills. Based on Component, the market is segmented into Ingestible Sensor, Wearable Receiver/Patch and Software & Analytics Platform. Based on Application, the market is segmented into Diagnostic Imaging, Medication Adherence Tracking and Targeted Drug Delivery. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, Home Healthcare and Research Institutes. Based on Disease Indication, the market is segmented into Gastro-intestinal Disorders, Oncology, Obesity & Metabolic Disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Drug Delivery Market

The increasing incidence of gastrointestinal disorders, including Crohn's disease, colorectal cancer, and chronic illnesses like diabetes, significantly contributes to the expansion of the smart pills drug delivery market. These conditions require continuous monitoring and precise diagnostics, making smart pills crucial for early detection and targeted drug administration. Additionally, they play a vital role in improving long-term management strategies for these diseases, ultimately offering a more effective approach to healthcare. As the demand for innovative solutions in disease treatment grows, smart pills are positioned as essential tools in the realm of modern medicine, enhancing patient outcomes and overall healthcare efficiency.

Restraints in the Global Smart Pills Drug Delivery Market

The Global Smart Pills Drug Delivery market faces significant challenges due to the high costs associated with these advanced technologies, which limit their accessibility for numerous patients and healthcare providers. The steep expenses linked to the manufacturing and deployment of smart pills create obstacles for hospitals, especially in budget-constrained settings. Furthermore, the lack of extensive insurance coverage exacerbates this issue, presenting a notable barrier to the widespread adoption of smart pill technology. Consequently, these financial constraints hinder the potential for large-scale implementation in the healthcare sector, restricting the benefits that smart pills could offer to many individuals in need of innovative treatment solutions.

Market Trends of the Global Smart Pills Drug Delivery Market

The Global Smart Pills Drug Delivery market is witnessing a transformative trend as the integration of artificial intelligence (AI) into smart pills revolutionizes patient care. These innovative capsules will capabilities to analyze real-time data and offer predictive insights, enhancing the management of chronic diseases by identifying anomalies before they escalate. Furthermore, AI will facilitate tailored medication regimens by recommending optimal dosing times, thereby improving adherence and outcomes. Seamlessly linking with electronic health records, these smart pills support a shift towards precision medicine, enabling a personalized healthcare experience. This paradigm shift positions AI-enhanced smart pills at the forefront of future pharmaceutical advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Customer Buying Behavior Analysis
Case Studies

Global Smart Pills Drug Delivery Market Size by Type & CAGR (2026-2033)

Market Overview
Capsule Endoscopy
Patient Monitoring Smart Pills
Drug-Delivery Smart Pills

Global Smart Pills Drug Delivery Market Size by Component & CAGR (2026-2033)

Market Overview
Ingestible Sensor
Wearable Receiver/Patch
Software & Analytics Platform

Global Smart Pills Drug Delivery Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostic Imaging
Medication Adherence Tracking
Targeted Drug Delivery

Global Smart Pills Drug Delivery Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Diagnostic Centers
Home Healthcare
Research Institutes

Global Smart Pills Drug Delivery Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Gastro-intestinal Disorders
Oncology
Obesity & Metabolic Disorders
Others

Global Smart Pills Drug Delivery Market Size & CAGR (2026-2033)

North America (Type, Component, Application, End User, Disease Indication)
- US
- Canada
Europe (Type, Component, Application, End User, Disease Indication)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Component, Application, End User, Disease Indication)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Component, Application, End User, Disease Indication)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Component, Application, End User, Disease Indication)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapsoVision Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinshan Science & Tech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Check-Cap Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
etectRx Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Pharmaceutical Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HQ Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IntroMedic Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BodyCap Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Digital Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RF Tracking Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AnX Robotica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chongqing Science & Tech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Karl Storz SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments